Brief: Amicus Therapeutics Reports Provides 2023 Strategic Outlook

Amicus Therapeutics

09/01/2023 12:43

Jan 9 (Reuters) - Amicus Therapeutics Inc  FOLD.O :
    * AMICUS THERAPEUTICS REPORTS PRELIMINARY 2022 REVENUE AND
PROVIDES 2023 STRATEGIC OUTLOOK
    * AMICUS THERAPEUTICS INC Q4 REVENUE $88.0 MILLION
    * AMICUS THERAPEUTICS - PRELIMINARY 2022 FULL YEAR REVENUE
OF
ABOUT $329 MILLION, REPRESENTING 16% YOY GROWTH AT CER
    * AMICUS THERAPEUTICS INC - ON-TRACK TO ACHIEVE NON-GAAP
PROFITABILITY IN 2H2023
    * AMICUS THERAPEUTICS INC - FOR FULL-YEAR 2023, COMPANY
ANTICIPATES DOUBLE-DIGIT GALAFOLD REVENUE GROWTH OF 12%-17% AT
CER

Source text for Eikon:  ID:nGNXbFQy5y 
Further company coverage:  FOLD.O 
 ((Reuters.Briefs@thomsonreuters.com;))